English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background. The aim of the study was to perform and evaluate pelvic venoablation with N-butyl-2-cy- anoacrilate (NBCA) and lipiodol injection into the deep dorsal vein for the treatment of 32 patients with venogenic erectile dysfunction. Methods. A total of 32 patients with the confirmed diagnosis of venogenic erectile dysfunction, with (n=15) or without (n=17) associated comorbidities were included. Deep dorsal veins were embolized with NBCA and lipiodol mixture. All patients were evaluated using the erectile function domain of the International Index of Erectile Function questionnaire (IIEF) before, at 3 months and 1 year after embolization. Results. While the post-operative 3rd month scores were increased significantly in all groups (p<0.001), there was a significant decrease at 12th month when compared to that of 3rd month (p<0.001). But this de- crease was significantly higher than those of preoperative values (p<0.001). In patients without comorbidi- ties post-operative 3rd and 12th month scores were significantly higher than that of patients with comorbidi- ties (p<0.04 and p<0.02, respectively). Although scores at 12th month were significantly higher compared to

Deep dorsal vein embolization with N-butyl-2-cyanoacrylate and lipiodol mixture in venogenic erectile dysfunction: early and late results